ACTUATE THERAPEUTICS INC (ACTU) Stock Analyst Ratings
USA - NASDAQ:ACTU - US0050831009 - Common Stock
6.66 USD
+0.08 (+1.22%)
6.66 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to ACTU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.29. This target is 309.68% above the current price.
ACTU was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ACTU.
In the previous month the buy percentage consensus was at a similar level.
ACTU was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-26 | B. Riley Securities | Initiate | Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Initiate | Buy |
ACTUATE THERAPEUTICS INC / ACTU FAQ
What is the price target for ACTU stock?
10 analysts have analysed ACTU and the average price target is 27.29 USD. This implies a price increase of 309.68% is expected in the next year compared to the current price of 6.66.
How do analysts rate ACTUATE THERAPEUTICS INC (ACTU)?
The consensus rating for ACTUATE THERAPEUTICS INC (ACTU) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ACTU stock?
The number of analysts covering ACTUATE THERAPEUTICS INC (ACTU) is 10.